Unique ID issued by UMIN | UMIN000014108 |
---|---|
Receipt number | R000016424 |
Scientific Title | Comparative study on hypotensive effect by administration timing of L/N-type calcium channel blocker cilnidipine in chronic kidney disease patients |
Date of disclosure of the study information | 2014/06/01 |
Last modified on | 2014/05/29 16:09:54 |
Comparative study on hypotensive effect by administration timing of L/N-type calcium channel blocker cilnidipine in chronic kidney disease patients
Hypotensive effect by administration timing of cilnidipine in chronic kidney disease patients
Comparative study on hypotensive effect by administration timing of L/N-type calcium channel blocker cilnidipine in chronic kidney disease patients
Hypotensive effect by administration timing of cilnidipine in chronic kidney disease patients
Japan |
Hypertension with chronic kidney disease
Medicine in general | Nephrology |
Others
NO
We aim to elucidate the improvement effect of adjustment at medication time of cilnidipine for CKD patients with hypertension.
It is expected that the different medication time of cilnidipine may cause the different effect on diurnal blood pressure variation characteristics.
We randomly assign medication time of cilnidipine to two groups (morning internal use group and night internal use group), then continue 24 weeks medication.
We evaluate the improvement effect for diurnal blood pressure variation characteristics and cardiovascular kidney protection in these groups by ambulatory blood pressure monitoring (ABPM) and other examinations.
Safety,Efficacy
Ambulatory blood pressure monitoring (ABPM)
1)BW, obesity, abdominal circumference.
2)Clinical blood pressure
3)Renal function
4)Cardiovascular function(Echocardiographic study, AI, ABI/baPWV), CAVI, Sympathetic nerve activity)
5)Blood examination
6)Lipid metabolism
7)Inflammatory marker
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
Numbered container method
2
Treatment
Medicine |
morning internal use group:patients are given 5-20mg of cilnidipine in morning.
night internal use group:patients are given 5-20mg of cilnidipine at bedtime.
20 | years-old | <= |
Not applicable |
Male and Female
1.CKD stage G1-5.
2.Hypertension:systolic blood pressure 130 mmHg or diastolic blood pressure 80 mmHg.
1.Dialysis patients.
2.Clinical blood pressure is 180/100mmHg or more in antihypertensive treatment.
3.Patients already received cilnidipine.
4.Patients with a history of hypersensitivity to cilnidipine.
5.Pregnant women or women who are suspect of pregnancy.
6.Patients judged as inappropriate for the study.
50
1st name | |
Middle name | |
Last name | Kouichi Tamura |
Yokohama City University School of Medicine
Department of Cardiorenal Medicine
3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, JAPAN
045-787-2635
tamukou@med.yokohama-cu.ac.jp
1st name | |
Middle name | |
Last name | Kouichi Tamura |
Yokohama City University School of Medicine
Department of Cardiorenal Medicine
3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, JAPAN
045-787-2635
tamukou@med.yokohama-cu.ac.jp
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
self
Self funding
JAPAN
NO
横浜市立大学附属病院
2014 | Year | 06 | Month | 01 | Day |
Unpublished
Open public recruiting
2014 | Year | 06 | Month | 01 | Day |
2014 | Year | 06 | Month | 01 | Day |
2014 | Year | 05 | Month | 29 | Day |
2014 | Year | 05 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016424